(Q38825771)

6 September 2017

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells (English)

1 reference

Alfonso R Sánchez-Paulete

6 September 2017

1 reference

1 reference

1 reference

Francisco J Cueto

2

0 references

object named as

Alfonso R Sánchez-Paulete

1

0 references

David Sancho

object named as

David Sancho

11

0 references

Ignacio Melero, MD-PhD

12

object named as

Ignacio Melero

1 reference

6 September 2017

María Martínez-López

3

1 reference

6 September 2017

Sara Labiano

4

1 reference

6 September 2017

Aizea Morales-Kastresana

5

1 reference

6 September 2017

María E Rodríguez-Ruiz

6

1 reference

6 September 2017

Maria Jure-Kunkel

7

1 reference

6 September 2017

Arantza Azpilikueta

8

1 reference

6 September 2017

M Angela Aznar

9

1 reference

6 September 2017

José I Quetglas

10

1 reference

6 September 2017

22 October 2015

1 reference

6 September 2017

1 reference

6 September 2017

6

1 reference

6 September 2017

1

1 reference

6 September 2017

71-79

1 reference

Neoantigens in cancer immunotherapy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

9 September 2017

Defining dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Agonist antibodies to TNFR molecules that costimulate T and NK cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Compensatory dendritic cell development mediated by BATF-IRF interactions

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Cross-presentation by dendritic cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

PD-1 and its ligands in tolerance and immunity

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Immunosuppressive strategies that are mediated by tumor cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Palettes of vaccines and immunostimulatory monoclonal antibodies for combination.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

22 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5036540

Antitumour immunity gets a boost

22 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26493961

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26493961

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26493961

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/2159-8290.CD-15-0510

1 reference

6 September 2017

1 reference

6 September 2017

1 reference